FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Oxytocin Injection, USP Synthetic
Status: Currently in Shortage
»Date first posted: 11/06/2019
»Therapeutic Categories: Reproductive

Expand all

Fresenius Kabi USA, LLC (Revised 12/09/2019)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial; (NDC 63323-012-10) Backordered. Next release December 2019. Check wholesalers for inventory Delay in manufacturing
300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30) Backordered. Next release January 2020. Delay in manufacturing
10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01) Backordered. Next release November. Check wholesalers for inventory Delay in manufacturing

Par Pharmaceutical (New 11/06/2019)

Company Contact Information:
800-828-9393

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06) Available
Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25) Available
Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English